期刊文献+

短疗程适形非常规放疗同步EP方案化疗Ⅲ期非小细胞肺癌68例 被引量:1

Synchro EP of extraordinary gauge of short course of treatment shape suitable radiotherapy scheme chemotherapy Ⅲ in non-cellule lung cancer phase of 68 cases
下载PDF
导出
摘要 目的探讨非小细胞肺癌(NSCLC)短疗程适形非常规放疗同步EP方案化疗的疗效。方法Ⅲ期NSCLC患者68例,第1周采用适形常规放疗,2GY/次,照射5次,周六、日休息;然后采用常规大剂量放疗3GY/次,5次/周,照射10次;第4周与第1周治疗方式相同;第5周3GY/次,照射3次;共31d完成全部放疗,等效生物剂量为70GY。化疗采用EP方案:第1、2、3天VP-1680mg/m2,静脉滴注;第1天PDD60mg/m2静脉滴注。21d为1个周期,于照射当天同时行静脉化疗。同步放化疗结束后第3周再行3周期强化静脉化疗。结果近期有效率为89.7%,1、2、3年生存率为73.5%、39.7%、22.1%;中位生存期为19.6个月。结论短疗程适形非常规放疗同步EP方案化疗Ⅲ期NSCLC有较好疗效,不良反应可以耐受。 Objective Explore the treatment effect of non-cellule lung cancer(NSCLC) owes a course of treatment the synchro EP of extraordinary shape gauge suitable radiotherapy scheme chemotherapy. Methods Ⅲ expects the NSCLC patients of 68 cases ,the first cycles adopted the shape routine radiotherapy suitable ,2 GY/irradiate 5 times, gradually have a rest Saturday, Adopt large dosages of routine then radiotherapy 3 GY/are inferior,5 times off/cycles,irradiate 10 times;The fourth cycles and the first cycles were treated is identical;the Fifth cycle 3 GY/irradlate 3 times ,31 days accomplishes all radiotherapies ,equivalent living things dosages are 70 GY. The chemotherapy adopt the EP scheme:VP-16 80 mg/m2 quiescent point the 1 st,2nd,3nd day; PDD 60 mg/m2 quiescent point 1 st day. 21 days is a period ,in irradiating the very day performing the vein chemotherapy at the same time. Put in a chemotherapy synchroly 3 periods ending last third strengthen the vein chemotherapy. Results The efficiency in the near future is 89.7% ,the survival rate is 73.5% ,39.7% ,22. 1% for1,2,3 years respectivelly; The median place life cycle is 19.6 months. Conclusion Synchro EP of extraordinary gauge of short course of treatment shape suitable radiotherapy scheme chemotherapy Ⅲ scheduled time NSCLC has the fairly treatment effect ,The patient could endure the side-effects.
出处 《中国实用医药》 2008年第9期26-28,共3页 China Practical Medicine
关键词 肺癌 适形放疗 短疗程 非常规 化疗 同步 Lung cancer Shape radiotherapy suitable Short course of treatment Extraordinary gauge Chemotherapy Synchro
  • 相关文献

参考文献7

  • 1吴开良,蒋国梁,廖源,钱浩,王丽娟,赵森.非小细胞肺癌三维适形放射治疗临床Ⅰ和Ⅱ期剂量递增试验结果分析[J].中华放射肿瘤学杂志,2003,12(1):10-13. 被引量:113
  • 2[2]Dillman RO,Seagren SL,Propert KJ,et al.Effects of concomitant cisplatin and radiotherapy oninoperablenon-small cell lung cancer.N Engl J Med,1990,323:940.
  • 3[3]Le CT,Arriagada R,Quoix E,et al.One hour paclitaxel in the treatment of non-small cell lung cancer.J Natl cancerlist,1992,84:58.
  • 4[4]Jeremic B,Shibamoto Y,Acimoric L,et al.Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage Ⅲ nonsmall-cell lung cancer:randomized study.J Clin oncol,1996,14:1065-1107.
  • 5[5]Byhanlt BW,Scott CB,Ettinger DS,et al.Concurrent hyperfrac tionated irradiation and chemotherapy for unresectable non-small cell lung cancer,results of radiation therapy oncology group 90~15 Cancer,1995,75:2337-2344.
  • 6[6]Bghardt RW,Turning up the heat on nonsmall cell lung cancer:Is the toxicity of concurrent cisplatin-based chemotherpay and accelerated fractionated irradiation acceptable?Int J Radiat Oncol Biol phys,1994,31:267-272.
  • 7刘欣红,贺方学,张秀芝,王翠微.后程适形放疗同期化疗治疗Ⅲ期非小细胞肺癌[J].临床肿瘤学杂志,2005,10(4):413-415. 被引量:1

二级参考文献6

  • 1徐夔渊 俞受程 等.现代肿瘤放射治疗学[M].北京:人民军医出版社,2000.727.
  • 2Caffo O.Radiosensitization with chemotherapeutic agents[J].Lung Cancer,2001,34(Suppl 4):S81-S90.
  • 3Shigematsu N,Kawata T,Ihara N,et al.Effect of combined treatment with radiation and low dose etoposide on cell survival[J].Anticancer Res,2001,21(1A):325-328.
  • 4Rosenzweig KE,Sim SE,Mychalczak B,et al.Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy[J].Int J Ratiat Oncol Biolphys,2001,50(3):681-685.
  • 5陈桂园,王丽娟,蒋国梁.中晚期非小细胞肺癌化疗和放疗综合治疗进展[J].中国癌症杂志,2000,10(4):357-359. 被引量:42
  • 6蒋国樑.我国肺癌放射治疗的现状与展望[J].中国肺癌杂志,2000,3(5):321-321. 被引量:10

共引文献112

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部